Showing results (1591-1600 of 2,626) with videos related to
Sort By:
Pageof 263
Pain Medicine (Malden, Mass.)|March 21, 2022
The Uptake and Effectiveness of a Multidisciplinary Online Program for Managing Chronic Pain before and During the COVID-19 PandemicChristine T Shiner, Tania Gardner, Hila Haskelberg, et al.Elife|July 4, 2015
Optogenetic feedback control of neural activityJonathan P Newman, Ming-fai Fong, Daniel C Millard, et al.The British Journal of Dermatology|March 17, 2001
Familial clustering of polymorphic light eruption in relatives of patients with lupus erythematosus: evidence of a shared pathogenesisT P Millard, C M Lewis, M A Khamashta, et al.The British Journal of Dermatology|December 22, 1999
Reactivation of cutaneous leishmaniasis after surgeryR T Czechowicz, T P Millard, H R Smith, et al.The Journal of Asthma : Official Journal of the Association for the Care of Asthma|November 25, 2003
A randomized controlled trial using the school for anti-inflammatory therapy in asthmaMark Warren Millard, Pauline T Johnson, Melanie McEwen, et al.Endocrinology|February 1, 1995
Measurement of growth hormone-binding protein in the rat by a ligand immunofunctional assayK C Leung, W J Millard, E Peters, et al.Emerging Infectious Diseases|August 17, 2005
Estimating foodborne gastroenteritis, AustraliaGillian Hall, Martyn D Kirk, Niels Becker, et al.British Journal of Haematology|July 20, 2004
Increased hepcidin expression and hypoferraemia associated with an acute phase response are not affected by inactivation of HFEDavid M Frazer, Sarah J Wilkins, Kirstin N Millard, et al.Pediatrics|March 3, 2006
Parents' perceptions of their child's weight and healthKathryn C Eckstein, Laura M Mikhail, Adolfo J Ariza, et al.Antimicrobial Agents and Chemotherapy|December 12, 2007
Hepatotoxicity observed in clinical trials of aplaviroc (GW873140)W G Nichols, H M Steel, T Bonny, et al.Pageof 263